ScoreComparison
Why is Wuxi Biologics (Cayman), Inc. ?
1
Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 47.82
2
Healthy long term growth as Net Sales has grown by an annual rate of 35.21% and Operating profit at 41.97%
3
Flat results in Jun 25
- INTEREST(HY) At HKD 89.74 MM has Grown at 21.65%
4
With ROE of 9.88%, it has a Fair valuation with a 3.06 Price to Book Value
- Over the past year, while the stock has generated a return of 33.26%, its profits have risen by 8.3% ; the PEG ratio of the company is 2.9
5
Market Beating Performance
- The stock has generated a return of 33.26% in the last 1 year, much higher than market (Hang Seng Hong Kong) returns of 8.25%
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Wuxi Biologics (Cayman), Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Wuxi Biologics (Cayman), Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Wuxi Biologics (Cayman), Inc.
-100.0%
3.79
54.76%
Hang Seng Hong Kong
8.25%
0.41
19.93%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
35.21%
EBIT Growth (5y)
41.97%
EBIT to Interest (avg)
47.82
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.19
Sales to Capital Employed (avg)
0.36
Tax Ratio
18.39%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.02%
ROCE (avg)
13.03%
ROE (avg)
9.46%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
31
Industry P/E
Price to Book Value
3.06
EV to EBIT
25.73
EV to EBITDA
18.90
EV to Capital Employed
3.54
EV to Sales
6.32
PEG Ratio
2.85
Dividend Yield
NA
ROCE (Latest)
13.78%
ROE (Latest)
9.88%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend5What is working for the Company
INTEREST COVERAGE RATIO(Q)
Highest at 4,283.69
RAW MATERIAL COST(Y)
Fallen by -1.95% (YoY
CASH AND EQV(HY)
Highest at HKD 13,752.63 MM
EPS(Q)
Highest at HKD 0.59
-2What is not working for the Company
INTEREST(HY)
At HKD 89.74 MM has Grown at 21.65%
Here's what is working for Wuxi Biologics (Cayman), Inc.
Interest Coverage Ratio
Highest at 4,283.69
in the last five periodsMOJO Watch
The company's ability to manage interest payments is improving
Operating Profit to Interest
EPS
Highest at HKD 0.59
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (HKD)
Cash and Eqv
Highest at HKD 13,752.63 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Raw Material Cost
Fallen by -1.95% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Wuxi Biologics (Cayman), Inc.
Interest
At HKD 89.74 MM has Grown at 21.65%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (HKD MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
